Rithm Capital Corp. (RITM) · Oct 23, 2026 · Earnings
Beat — EAD $0.55 vs ~$0.494 consensus; revenue $1.76B vs ~$1.47B
Rithm Capital earnings beat Q3 estimates on stronger servicing and mortgage operations, while distribution earnings fell sequentially and the dividend stayed flat.
Rithm is trying to evolve from a mortgage-centered REIT into a diversified owner-operator spanning mortgage servicing, lending, alternative asset management and commercial real estate. Its broader strategy already includes Newrez, Genesis, Sculptor, Crestline and Elecor, with management targeting a roughly $100 billion investable-asset platform.
The quarter beat the published benchmark, but the quality of the beat is mixed. Earnings available for distribution came in at $0.55 per diluted share versus a published consensus of roughly $0.494, while revenue reached $1.76 billion against approximately $1.47 billion expected. That is a clear earnings beat, although EAD declined from $0.60 in Q2. GAAP EPS rebounded to $0.38 from $0.04, but the comparison was heavily helped by a swing in MSR fair-value results from a $392.9 million loss to a $121.3 million gain. (Non-GAAP Financial Measures and Reconciliation to GAAP Net Income; Income Statement)
| Metric | Q3 2026 | Q2 2026 | Comparison |
|---|---|---|---|
| Earnings available for distribution per diluted share | $0.55 (Non-GAAP Reconciliation) | $0.60 (Non-GAAP Reconciliation) | Published consensus: ~$0.494 |
| GAAP net income per diluted share | $0.38 (Summary Operating Results) | $0.04 (Summary Operating Results) | MSR valuation swing drove much of the improvement |
| Total revenue | $1.756B (Income Statement) | $1.282B (Income Statement) | Published consensus: ~$1.47B |
| Common dividend per share | $0.25 (Summary Operating Results) | $0.25 (Summary Operating Results) | Unchanged |
| Newrez pre-tax operating income, excluding MSR MTM and other non-operating items | $329.7M (Summary Operating Results) | $307.6M (Summary Operating Results) | Improved sequentially |
| Asset-management AUM | ~$61B (Summary Operating Results) | ~$61B (Summary Operating Results) | Flat sequentially |
| Genesis residential-transition-loan originations | $1.5B (Summary Operating Results) | Not provided | Up 25% year over year |
The underlying operating platforms improved, especially Newrez and Genesis. Newrez’s pre-tax operating income excluding MSR mark-to-market and other non-operating items rose to $329.7 million from $307.6 million. Genesis originated $1.5 billion of residential transition loans, up 25% year over year. These figures make the beat more substantive than a pure accounting rebound.
The diversification story advanced, but did not accelerate everywhere. Rithm completed a joint venture for 1301 Avenue of the Americas while retaining a significant interest and operating role. 〔0〕 Elecor also lifted year-to-date leasing to 1.0 million square feet at rents 22% above fiscal 2025 levels, while asset-management AUM held at approximately $61 billion rather than expanding.
The unchanged dividend limits the immediate distribution signal. EAD still covered the $0.25 common dividend by more than two times, but management did not raise the payout despite the quarterly beat, leaving the capital-allocation message steady rather than newly bullish. The filing therefore strengthens confidence in operating execution more than it changes the dividend or asset-management trajectory.
Bottom line: Rithm delivered a genuine earnings and revenue beat, supported by stronger recurring mortgage operations and loan production. The result advances the diversification story, but sequential EAD softness, flat AUM and an unchanged dividend keep it from being a clean acceleration signal.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!